Profilo
Colin J. Meyer è Chief Research & Development Officer, Executive VP presso Reata Pharmaceuticals, Inc. Ha conseguito una laurea presso l'Università della Virginia, un dottorato presso l'Università del Texas Southwestern Medical Center e un MBA presso la SMU-Cox School of Business.
Precedenti posizioni note di Colin Meyer
Società | Posizione | Fine |
---|---|---|
REATA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 07/02/2022 |
Formazione di Colin Meyer
University of Virginia | Undergraduate Degree |
The University of Texas Southwestern Medical Center | Doctorate Degree |
SMU-Cox School of Business | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
Reata Pharmaceuticals, Inc.
Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by J. Warren Huff in 2002 and is headquartered in Plano, TX. | Health Technology |
- Borsa valori
- Insiders
- Colin Meyer